Clinical Trials Browser

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT01438112 2021-04-14

BOND

Phase 2/3 Terminated

22 enrolled

Genitourinary

Adenoviridae Infections, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell, Neoplasms, Virus Diseases

NCT02186301 2019-05-07

EGFR

Phase 2/3 Terminated

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

Phase 2/3 Terminated

6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

NCT01931592 2017-05-08

CLEAR

Phase 2/3 Terminated

29 enrolled

Neoplasms, Neutropenia, Sepsis

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Phase 2/3 Terminated

2 enrolled 8 charts

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

Phase 2/3 Terminated

140 enrolled

Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

Clinical Trials

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

ORIGAMA

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

BOND

EGFR

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

CLEAR

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer